Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>The <em>Dang-Gui-Si-Ni</em> (DGSN) decoction as a classic prescription has been widely used for thousands of years in the clinical practice of traditional Chinese medicine (TCM). Especially in recent years, the potential efficacy of TCM for the treatment of Raynaud's syndrome has attracted great attention as there are still no specific remedies for this disease. However, the active constituents and underlying mechanisms responsible for the therapeutic benefits are not well understood, which makes it difficult to ensure quality control or to design research and drug development strategies. To identify the potential pharmacodynamic ingredients (PPIs) of TCM will help to achieve suitable process control procedures for industrial production and large-scale manufacturing.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>In the present study, we propose a multi-dimensional qualitative analysis method combining water-decoction spectra, <em>in-vitro</em> intestinal absorption spectra, <em>in-vivo</em> plasma spectra, and molecular docking of components to quickly identify the PPIs for the DGSN decoction of TCM.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>Water-based decoctions of DGSN were prepared in accordance with the clinical use registered in ancient books. Ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry (UHPLC-Q/TOF-MS) coupled with computerized modelling activity screening was used to quickly identify the PPIs of the DGSN decoction. Bioactive compounds absorbed <em>in vitro</em> were identified using the everted intestinal sac model from rats and compounds absorbed <em>in vivo</em> were confirmed in portal vein blood samples obtained following oral administration in rats. Molecular docking validation experiments were adopted to predict the binding activity to coagulation factors I, II, VII, X, and IX. The active components were further confirmed by pharmacodynamics analysis. The anticoagulant activity of the DGSN decoction was verified using rat models.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Thirty-one compounds were identified in the DGSN decoction. According to the <em>in vivo</em> experiments, 22 compounds that could be absorbed <em>in vivo</em> were detected by the everted intestinal sac model in rats. This model greatly reduces the scope of PPIs and is easy to perform. Ten compounds were detected in the portal vein blood in rats. The compounds detected in plasma provide stronger evidence supporting the PPIs. Molecular docking <em>in vitro</em> experiments indicated that 7 compounds exhibited better binding activity with coagulation factors I, II, VII, X, and IX. The animal experiments confirmed that the DGSN decoction could improve the microcirculation, providing indirect proof of anticoagulant activity suggested by the molecular docking studies. Finally, based on the multi-dimensional methods, 9 potential compounds present in the DGSN decoction were identified as PPIs (i.e., ferulic acid, paeoniflorin, albiflorin, chlorogenic acid, cryptochlorogenic acid, liquiritin, liquiritin apioside, cinnamaldehyde and glycyrrhizic acid).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Overall, this study combined the water-decoction spectra, intestinal absorption spectra <em>in vitro</em>, plasma spectra <em>in vivo,</em> and molecular docking studies to establish a multi-dimensional qualitative analysis method of the DGSN decoction. Meanwhile, 9 compounds in DGSN decoction were identified as PPIs using this method, and are proposed for application as quality standards for complex TCM prescriptions.</p>

Analysis of Herbal Constituents and in Vivo Pharmacokinetics of Gegen-Huangqi Decoction in Rat Plasma Using HPLC-Q-TOF-MS/MS and HPLC-QQQ-MS/MS.

Identification of Constituents in Gui-Zhi-Jia-Ge-Gen-Tang by LC-IT-MS Combined with LC-Q-TOF-MS and Elucidation of Their Metabolic Networks in Rat Plasma after Oral Administration.

Simultaneous Determination in Rat Plasma of Eleven Bioactive Components of Gengen Qinlian Decoction by LC-Tandem Mass Spectrometry and Application in Pharmacokinetic Studies

Simultaneous Quantification of 50 Bioactive Compounds of the Traditional Chinese Medicine Formula Gegen-Qinlian Decoction Using Ultra-High Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry

Identification of the absorbed constituents and metabolites of Huangqi Guizhi Wuwu decoction by ultrahigh-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry

[Analysis on ingredients and metabolites of Gegen Decoction absorbed into blood based on UHPLC-Q-TOF-MS]

HPLC-DAD-Q-TOF-MS/MS analysis and HPLC quantitation of chemical constituents in traditional Chinese medicinal formula Ge-Gen Decoction.

A comprehensive quality evaluation for Huangqi Guizhi Wuwu decoction by integrating UPLC-DAD/MS chemical profile and pharmacodynamics combined with chemometric analysis

Simultaneous Determination of Multiple Compounds of Da-Huang-Xiao-Shi Decoction in Rat Plasma by LC-MS/MS and Its Application in a Pharmacokinetic Study.

Tissue distribution and integrated pharmacokinetic properties of major effective constituents of oral Gegen-Qinlian decoction in mice

Kinetic features of Gualou-Xiebai-Banxia decoction, a classical traditional Chinese medicine formula, in rat plasma and intestine content based on its metabolic profile

Simultaneous Determination of Eight Bioactive Constituents of Zhi-Zi-Hou-Po Decoction in Rat Plasma by Ultra High Performance Liquid Chromatography with Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study

Tissue distribution and integrated pharmacokinetic properties of major effective constituents of oral <i>Gegen-Qinlian</i> decoction in mice

Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction

UHPLC-MS/MS Method for Quantifying Fangchinoline, Tetrandrine and Calycosin-7-O-β-D-Glucoside of Fangji Huangqi Decoction in Rat Plasma and Its Application to a Pharmacokinetic Study.

Plasma pharmacochemistry based approach to screening potential bioactive components in Huang-Lian-Jie-Du-Tang using high performance liquid chromatography coupled with mass spectrometric detection

Characterization of chemical constituents in Huangqi Guizhi Wuwu decoction using ultra‐high performance liquid chromatography coupled with quadrupole time‐of‐flight mass spectrometry

A systematic UHPLC-Q-TOF-MS/MS-based strategy for analysis of chemical constituents and related in vivo metabolites of Buyang Huanwu decoction

Discovery of potential pharmacodynamic ingredients of Dang-Gui-Si-Ni decoction based on absorbed ingredients and molecular docking

The Profiling and Identification of the Absorbed Constituents and Metabolites of Guizhi Decoction in Rat Plasma and Urine by Rapid Resolution Liquid Chromatography Combined with Quadrupole-Time-of-Flight Mass Spectrometry.

Identification and characterization of chemical constituents in Mahuang Guizhi Decoction and their metabolites in rat plasma and brain by UPLC-Q-TOF/MS